Rebuttal From Dr Chalmers

James D. Chalmers (Lead / Corresponding author)

Research output: Contribution to journal › Editorial › peer-review

ASJC Scopus subject areas

@article{dc3ce97590b940c79a801d6e53088166,

title = "Rebuttal From Dr Chalmers",

author = "Chalmers, {James D.}",

note = "J. D. C. reports research grants from GlaxoSmithKline, Boehringer-Ingelheim, AstraZeneca, and Pfizer.",

year = "2018",

month = apr,

doi = "10.1016/j.chest.2018.01.036",

language = "English",

volume = "153",

pages = "785--786",

journal = "Chest",

issn = "0012-3692",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Rebuttal From Dr Chalmers

AU - Chalmers, James D.

N1 - J. D. C. reports research grants from GlaxoSmithKline, Boehringer-Ingelheim, AstraZeneca, and Pfizer.

PY - 2018/4

Y1 - 2018/4

UR - http://www.scopus.com/inward/record.url?scp=85044147116&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2018.01.036

DO - 10.1016/j.chest.2018.01.036

M3 - Editorial

C2 - 29474808

SN - 0012-3692

VL - 153

SP - 785

EP - 786

JO - Chest

JF - Chest

IS - 4

ER -